Safety and Effectiveness of Microvascular Decompression for the Treatment of Hemifacial Spasm in the Elderly
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Youn, Jinyoung | - |
dc.contributor.author | Kwon, Soonwook | - |
dc.contributor.author | Kim, Ji Sun | - |
dc.contributor.author | Jeong, Heejeong | - |
dc.contributor.author | Park, Kwan | - |
dc.contributor.author | Cho, Jin Whan | - |
dc.date.accessioned | 2021-08-12T02:25:10Z | - |
dc.date.available | 2021-08-12T02:25:10Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 0014-3022 | - |
dc.identifier.issn | 1421-9913 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/14564 | - |
dc.description.abstract | Background: Hemifacial spasm (HFS) is a common disorder and has a significant impact on the quality of life. Microvascular decompression (MVD) is an effective and safe treatment option for patients with HFS, however the effectiveness and safety of MVD in elderly patients with HFS is not clear. Methods: We enrolled 699 HFS patients who underwent MVD from February 2008 to December 2011 at the Samsung Medical Center in Seoul, Korea. Subjects were divided into two groups: an elderly group (patients who were 60 years old or older) and a younger group. We compared demographic and clinical data, surgical outcome and complications after MVD between the groups. Results: The elderly group had more severe spasms and higher grade indentation than the younger group. Multiple offending vessels were more commonly detected in the elderly group. Although the improvement was similar 6 months after MVD between the groups, complications were more common in the elderly group even after controlling for possible confounding factors. In particular, ear problems including hearing loss were more common in the elderly group. Conclusion: MVD is an effective treatment option in elderly patients with HFS. However, surgeons should be pay attention to potential complications in elderly patients with HFS. Copyright (C) 2013 S. Karger AG, Basel | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | S. Karger AG | - |
dc.title | Safety and Effectiveness of Microvascular Decompression for the Treatment of Hemifacial Spasm in the Elderly | - |
dc.type | Article | - |
dc.publisher.location | 스위스 | - |
dc.identifier.doi | 10.1159/000351266 | - |
dc.identifier.scopusid | 2-s2.0-84881002568 | - |
dc.identifier.wosid | 000326135500008 | - |
dc.identifier.bibliographicCitation | European Neurology, v.70, no.3-4, pp 165 - 171 | - |
dc.citation.title | European Neurology | - |
dc.citation.volume | 70 | - |
dc.citation.number | 3-4 | - |
dc.citation.startPage | 165 | - |
dc.citation.endPage | 171 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.subject.keywordPlus | LONG-TERM TREATMENT | - |
dc.subject.keywordPlus | QUALITY-OF-LIFE | - |
dc.subject.keywordPlus | TRIGEMINAL NEURALGIA | - |
dc.subject.keywordPlus | PROGNOSTIC-FACTORS | - |
dc.subject.keywordPlus | HEARING-LOSS | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordAuthor | Hemifacial spasm | - |
dc.subject.keywordAuthor | Microvascular decompression | - |
dc.subject.keywordAuthor | Safety | - |
dc.subject.keywordAuthor | Efficacy | - |
dc.subject.keywordAuthor | Elderly | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.